Header cover image

German (DAX) Pharma Industry Analysis

UpdatedJun 24, 2022
DataAggregated Company Financials
Companies8
  • 7D-4.6%
  • 3M-9.4%
  • 1Y4.0%
  • YTD-14.0%

Over the last 7 days, the Pharma industry has dropped 4.6%, driven by declines in Bayer and MERCK Kommanditgesellschaft auf Aktien of 5.2% and 4.4%, respectively. In contrast, Dermapharm Holding has gained 5.7%. This takes the industry's 12 month performance to a gain of 4.0%. Looking forward, earnings are forecast to grow by 6.5% annually.

Industry Valuation and Performance

Has the German Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sat, 25 Jun 2022€128.4b€67.8b€5.6b21.3x
Mon, 23 May 2022€140.8b€67.8b€5.6b23.5x
Wed, 20 Apr 2022€147.2b€64.9b€4.3b29.7x
Fri, 18 Mar 2022€142.6b€64.8b€4.2b29.3x
Sun, 13 Feb 2022€136.3b€63.1b€3.1b31.6x
Tue, 11 Jan 2022€140.0b€63.1b€3.1b34x
Thu, 09 Dec 2021€146.1b€63.1b€3.1b34.4x
Sat, 06 Nov 2021€148.8b€61.2b-€4,717,516,252.0035.9x
Mon, 04 Oct 2021€130.3b€61.2b-€4,717,516,252.0033.7x
Wed, 01 Sep 2021€139.6b€61.2b-€4,716,670,252.0034x
Thu, 08 Jul 2021€124.8b€61.2b-€4,716,670,252.0029.4x
Wed, 31 Mar 2021€120.1b€59.6b-€12,510,147,423.0027.9x
Sat, 02 Jan 2021€111.8b€59.8b-€13,556,792,870.0030.7x
Tue, 06 Oct 2020€109.5b€60.3b-€14,034,964,373.3828.7x
Fri, 10 Jul 2020€112.5b€61.3b-€5,793,814,704.0031.1x
Thu, 02 Apr 2020€94.8b€61.7b€4.3b25.2x
Sun, 05 Jan 2020€119.6b€60.5b€3.8b28.8x
Wed, 09 Oct 2019€107.4b€59.5b-€330,531,806.0032.9x
Tue, 02 Jul 2019€98.4b€58.6b€1.5b35.8x
Median PE Ratio

35.8x


Total Market Cap: €98.4bTotal Earnings: €1.5bTotal Revenue: €58.6bTotal Market Cap vs Earnings and Revenue0%0%0%
German Pharma Industry Median PE3Y Average 30.8x202020212022
Current Industry PE
  • Investors are pessimistic on the industry, indicating that they anticipate long-term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 22.9x which is higher than its 3-year average PE of -17.5x.
  • The industry is trading close to its 3-year average PS ratio of 2.0x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 56% per year over the last three years.
  • Revenues for these companies have grown 5.0% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does German Pharma compare with similar industries?

DE Market-1.22%
Healthcare-2.82%
Pharma-4.57%
Pharma-4.57%
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
MRK MERCK Kommanditgesellschaft auf Aktien€164.804.2%
+€2.9b
4.0%PS22.5x
DMP Dermapharm Holding€46.826.3%
+€149.7m
-31.6%PS12x
PSG PharmaSGP Holding€23.902.1%
+€6.0m
5.3%PS25.6x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

B8F

€1.20

Biofrontera

7D

-6.3%

1Y

-58.8%

BAYN

€57.79

Bayer

7D

-7.6%

1Y

11.6%

SBX

€14.42

SynBiotic

7D

-16.4%

1Y

-29.7%